SB
REGN icon

Strategic Blueprint’s Regeneron Pharmaceuticals REGN Stock Holding History

Strategic Blueprint’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,788
Closed -$2.4M – 726
2025
Q1 		$2.4M Sell
3,788
-73
-2% -$50.2K 0.13% 154
2024
Q4 		$2.75M Sell
3,861
-226
-6% -$190K 0.16% 119
2024
Q3 		$4.3M Sell
4,087
-36
-0.9% -$40.1K 0.27% 89
2024
Q2 		$4.33M Sell
4,123
-53
-1% -$51.4K 0.29% 85
2024
Q1 		$4.02M Sell
4,176
-856
-17% -$814K 0.29% 85
2023
Q4 		$4.42M Buy
5,032
+106
+2% +$87.3K 0.36% 66
2023
Q3 		$4.05M Buy
4,926
+295
+6% +$232K 0.37% 62
2023
Q2 		$3.33M Buy
4,631
+131
+3% +$101K 0.32% 72
2023
Q1 		$3.7M Buy
4,500
+768
+21% +$579K 0.38% 59
2022
Q4 		$2.69M Sell
3,732
-99
-3% -$73K 0.31% 81
2022
Q3 		$2.64M Sell
3,831
-1,126
-23% -$709K 0.32% 81
2022
Q2 		$2.93M Sell
4,957
-170
-3% -$111K 0.36% 73
2022
Q1 		$3.58M Sell
5,127
-6,372
-55% -$4.03M 0.42% 56
2021
Q4 		$7.26M Buy
11,499
+2,312
+25% +$1.42M 0.92% 15
2021
Q3 		$5.56M Buy
9,187
+265
+3% +$165K 0.86% 20
2021
Q2 		$4.98M Buy
8,922
+4,468
+100% +$2.26M 0.78% 20
2021
Q1 		$2.11M Buy
+4,454
New +$2.17M 0.45% 56
2020
Q3 		– Sell
-489
Closed -$305K – 227
2020
Q2 		$305K Buy
+489
New +$278K 0.11% 123

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Strategic Blueprint's REGN Position: Q2 2025 in Review

Strategic Blueprint sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 3,788 shares — an estimated $2.4M sold.

Strategic Blueprint first reported a position in REGN in Q2 2020 and held it in 18 quarters. The position peaked at $7.26M in Q4 2021. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Strategic Blueprint reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Strategic Blueprint sold 3,788 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $2.4M.
  • Strategic Blueprint first reported a position in Regeneron Pharmaceuticals in Q2 2020 and held it in 18 quarters.
  • Strategic Blueprint's Regeneron Pharmaceuticals position peaked at $7.26M in Q4 2021.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Strategic Blueprint's 13F filing for Q2 2025, filed 30 Jul 2025.